6 Dimensions Capital — Full Portfolio

Kymera is a clinical-stage biotechnology company developing novel medicines using targeted protein degradation technology to treat diseases caused by previously "undrugged" proteins.

BiotechDeep TechHealthtech

NMNello Mainolfi(Founder)inBBBruce Booth(Chair)in

Co-investorsATAtlas VentureAVAvoro Capital AdvisorsBABain Capital Life SciencesBEBessemer Venture PartnersHAHatteras Venture PartnersMRMRL Ventures Fund+7 more

Dewpoint Therapeutics develops condensate-modulating drugs by using an integrated platform that maps, measures, and modulates biomolecular condensates to identify druggable targets and disease mechanisms.

AI & Machine LearningBiotechDeep TechBoston, US

RYRichard Young, Ph.D.(Director)inAHAnthony Hyman, Ph.D.(Director)THTony Hyman(Scientific Co-founder)Rick Young(Scientific Co-founder)Elisabeth Leiderman(Executive Officer)inIsaac Klein, M.D., Ph.D.(Executive Officer)

Co-investorsARARCH Venture PartnersECEcoR1 CapitalGEGeneral CatalystSASamsara BioCapitalINInnovation EndeavorsLELeaps by Bayer+6 more

A company focused on developing clinical treatments aimed at improving patient outcomes.

BiotechHealthtechMedical DevicesBoston, US

DSDavid Southwell(Executive Officer, Director)inRobert Crane(Executive Officer)

BoardLHLea Hachigian(Director)SKSteve Kraus(Director)inCMCampbell Murray(Director)in

Board seatHSHannes Smarason· per SEC Form D

Co-investorsASAstellas Venture Management LLCBEBessemer Venture PartnersGVGV (Google Ventures)LOLongwood FundRARA CapitalPIPitango

AnchorDx develops, manufactures, and sells cancer early-screening and diagnostic products based on ctDNA methylation high-throughput sequencing, along with related testing services covering over 70% of high-incidence cancers such as lung, breast, digestive, and urinary cancers.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesGuangzhou, CN

范建兵(Founder)

Co-investorsMAMarathon Venture PartnersOROrbiMed

Aspect Biosystems develops bioprinted tissue therapeutics using a platform that combines AI-powered bioprinting, computational design tools, therapeutic cells, and biomaterials to create implantable allogeneic tissues.

AI & Machine LearningBiotechLongevity

TMTamer Mohamed(Founder)inSWSam Wadsworth(Founder)inSBSimon Beyer(Founder)inLPLeela Paris(Chief Technical Operations Officer)inMSMike Scott(Chief Development Officer)inRSRay Smith(Chief Financial Officer)in

Co-investorsANAngel ForumCICivilization Ventures Management, LlcINInBC Investment Corp.JDJDRF T1D FundPAPage One VenturesPAPallasite Ventures+6 more

Automata provides lab automation and data management tools, enabling researchers and technicians to generate accurate data at scale through intuitive workflow creation.

Advanced ManufacturingAI & Machine LearningDeep TechHardwareHealthtechLegalTechRoboticsSaaSLondon, GB

MEMostafa ElSayed(Founder)inSuryansh Chandra(Founder)Suryansh Chandra Mostafa ElSayed(Founder)

Co-investorsAIAir Street CapitalBLBlue Wire CapitalENEntrepreneur FirstHCHCVCHUHummingbird VenturesINIn-Q-Tel+12 more

Hong Kong-listed (2137.HK) biotech founded in 2018 developing infectious disease therapies, led by hepatitis B functional-cure programs.

ZHZhi Hong(Founder)in

Co-investorsARARCH Venture PartnersBLBlue Pool CapitalBOBoyu CapitalSESequoia Capital

Centrexion develops therapies for the treatment of pain, focusing on the design and execution of clinical trials for pain drug development.

BiotechHealthtechBaltimore, US

JNJames N. Campbell(President, Chief Scientific Officer)inKLKerrie L. Brady(Executive Officer)inGregg Beloff(Executive Officer)JBJeffrey B. Kindler(Chief Executive Officer)inCOCharles Oh(Chief Medical Officer)inSSSmital Shah(Acting CBO)in

Co-investorsCACatalio Capital Management, LPEFEFung CapitalNENew Enterprise Associates (NEA)QUQuan CapitalAVAvoro Capital AdvisorsEXExome Asset Management

Convoke offers an AI platform that ingests and structures data from documents, scientific literature, SEC filings, and clinical data, and deploys custom agents to automate knowledge tasks and generate reports, manuscripts, and landscape analyses.

AI & Machine LearningBiotechEnterprise SoftwareHealthtechSaaS

Alex Telford(Founder)Maged Ahmed(Founder)Vikas Velagapudi(Founder)

Co-investorsAUAudaciousKLKleiner PerkinsACACMEACACME CapitalCOComma CapitalDIDimension Capital+3 more

Hong Kong-listed (HKEX: 2616) Chinese biopharmaceutical company developing oncology, immunology and inflammation therapies.

Co-investorsARARCH Venture PartnersBOBoyu CapitalGIGICHIHillhouse CapitalWUWuXi Healthcare Ventures

Fiveonefour builds tooling focused on agent experience (AX), helping developers ship software that AI agents can use effectively.

AI & Machine LearningDeveloper ToolsSaaSPortland, US

Timote Gelinas Delisle(Executive Officer, Director, Promoter)Chris Crane(Founder)inNJNicolas Joseph(Founder)in

BoardNLNan Li(Director)in

Co-investorsFLFlybridge Capital PartnersMAMaterialized View CapitalVEVermilion Cliffs VenturesDIDimension CapitalRIRidge VenturesSTStage 2 Capital

Frontera Therapeutics is a biotechnology company engaged in therapeutic research and development, spanning translational medicine, clinical operations, and manufacturing.

BiotechDeep TechHealthtechBoston, US

Xinyan Li(CEO)

Co-investorsOROrbiMedBOBoyu CapitalCRCreacion VenturesHOHongShan Capital Group

HiberCell develops therapeutic candidates targeting the Integrated Stress Response pathway to address treatment-resistant cancers, relapse, and metastasis.

BiotechMedical Devices

JAJulio Aguirre-Ghiso, Ph.D.(Co-Founder)

Co-investorsARARCH Venture PartnersMAMagnetic VenturesRARaptor GroupHEHercules Capital, Inc.HIHillhouse Capital

Shanghai-based, HKEX-listed drug developer commercializing dorzagliatin, the first approved glucokinase activator for type 2 diabetes.

Li Chen(Founder)

Co-investorsARARCH Venture PartnersF-F-Prime CapitalVEVenrockALAlly Bridge GroupBLBlue Pool CapitalEIEight Roads Ventures+2 more

Iterative Health is a healthcare technology and services company that combines clinical trial expertise with AI to help research teams and study sponsors expand and speed up patients' access to novel therapeutics.

AI & Machine LearningBiotechHealthtechCambridge, US

JNJonathan Ng(Executive Officer, Director)in

BoardPeter Moran(Director)NLNan Li(Director)inCharles Cooney(Director)

Co-investors51515 VenturesALAlumni VenturesBRBreyer CapitalG G Vision CapitalGVGV (Google Ventures)IKIKJ Capital+14 more

Odyssey Therapeutics develops small molecule and protein therapeutics targeting upstream signaling nodes and innate immune system mechanisms to prevent pathological inflammation.

BiotechMedical DevicesCambridge, US

GDGary D Glick(Executive Officer, Director)inGary D. Glick(Founder)

BoardJCJill Carroll(Director)inCGCarl Gordon(Director)inValerie Odegard(Director)Jeffrey Leiden(Director)

Co-investorsACActivant CapitalASAscenta CapitalBABalderton CapitalCACatalio Capital Management, LPFOForesite CapitalGLGlobal BioAccess Fund+9 more

Cambridge, MA biotech developing stem cell-derived islet therapy plus an immune-protective device for type 1 diabetes; acquired by Vertex for $950M.

BiotechCambridge, US

Robert Millman(Executive Officer, Director)

BoardTFTodd Foley(Executive Officer, Director)inMitch Finer(Director)SKStephen Knight(Director)inJim Scopa(Director)William Sahlman(Director)

Co-investorsARARCH Venture PartnersF-F-Prime CapitalJDJDRF T1D FundORORI CapitalSLSlater Technology FundCOCowen Healthcare Investments+4 more

Tamarind provides a computational platform for protein and molecular engineering, offering AI and physics-based tools to design antibodies, peptides, enzymes, and small molecules.

AI & Machine LearningBiotechDeep TechEnterprise SoftwareSaaSSan Francisco, US

DKDeniz Kavi(Founder)inSLSherry Liu(Founder)in

Co-investorsLYLynett Capital PartnersTRTranspose Platform ManagementTRTreeo VCY Y Combinator46468 CapitalDIDimension Capital+2 more

Vizgen develops high-throughput spatial profiling technologies, including MERFISH-based spatial genomics and spatial proteomics tools for life science research and precision oncology.

AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesCambridge, US

GEGeorge Emanuel(Scientific Cofounder, VP & Portfolio Owner, Instruments)inJiang He(Scientific Cofounder, VP & Portfolio Owner, Reagents & Scientific Affairs)inXZXiaowei Zhuang(Founder; Professor, Harvard University)inFenel Eloi(Director)RCRob Carson(Chief Executive Officer)inSimona Levi(Chief Legal Officer)in

Co-investorsARARCH Venture PartnersNONorthpond VenturesALAlly Bridge GroupAPApplied VenturesKIKilonova CapitalPUPura Vida Investments+3 more

Unity Biotechnology was a biotechnology company that is no longer operating.

BiotechBrisbane, US

NENathaniel E. David(Executive Officer, Director)inDMDan Marquess(Executive Officer)inKLKeith Leonard(Executive Officer, Director)inTTTamara Tompkins(Executive Officer)inBob Goeltz(Executive Officer)inJamie Dananberg(Executive Officer)in

Co-investorsAGage1ALAlumni VenturesARARCH Venture PartnersCYCycad Group LLCECEcoR1 CapitalKHKhosla Ventures+6 more

Verisian builds software for clinical research and public health authorities to analyze and monitor clinical trial data in real-time, improving decision-making and trial safety.

BiotechDigital HealthHealthtechSaaS

Henning Kuich(Founder)Tomas Sabat(Founder)

BoardSunil Gupta(Strategic Advisor)

Co-investorsCACambridge Angels groupRERecode VenturesSUSuperSeedMAManchesterStory Group, LLC